Trial Profile
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors to Everolimus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Mar 2023
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 01 Mar 2021 Planned number of patients changed from 20 to 30.
- 03 Nov 2020 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 03 Nov 2020 Planned primary completion date changed from 15 Sep 2020 to 15 Sep 2021.